Department of Pediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Yonsei Med J. 2021 Apr;62(4):370-373. doi: 10.3349/ymj.2021.62.4.370.
Research has shown mutations in the voltage-gated sodium channel gene to be associated with developmental delays and infantile seizures in patients with early-onset epileptic encephalopathies (EOEEs). Here, we report the case of an infant with a de novo mutation with EOEE who had medically refractory seizures that improved with a ketogenic diet (KD) implemented at an age less than 2 months. On the day of his birth, the infant presented with a pattern of convulsions with dozens of episodes per day. An initial video electroencephalogram revealed poor reactivity of background activity, with multiple partial episodes starting from the right temporal region, and abnormal electrical activity in the right hemisphere. The seizures previously were not controlled with successive therapy with phenobarbital, topiramate, and levetiracetam. Genetic testing revealed the presence of a mutation in the gene (c.4425C>G, p.Asn1475Lys). The infant's seizures decreased significantly with a combination of KD and medication. The present case exemplifies the potential for personalized genomics in identifying the etiology of an illness. Furthermore, the KD appears to feasible in infants younger than 2 months and might elicit good responses to EOEE associated with mutation.
研究表明,电压门控钠离子通道基因的突变与早发性癫痫性脑病(EOEE)患者的发育迟缓及婴儿期癫痫有关。本研究报告了一例患有 EOEE 的婴儿,其携带新生突变,且对药物难治性癫痫发作,在不到 2 个月大时开始接受生酮饮食(KD)治疗后得到改善。患儿出生时表现为数十次/天的惊厥模式。初始视频脑电图显示背景活动反应差,右侧颞区起始的多个部分发作,右半球异常电活动。之前,苯巴比妥、托吡酯和左乙拉西坦的连续治疗未能控制癫痫发作。基因检测显示存在 基因(c.4425C>G,p.Asn1475Lys)突变。KD 联合药物治疗后,患儿的癫痫发作明显减少。本病例说明了个性化基因组学在确定疾病病因方面的潜力。此外,KD 在 2 个月以下的婴儿中似乎是可行的,并且可能对与 突变相关的 EOEE 产生良好的反应。